Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery
Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.
In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.
Download whitepaper
Sano's commitment to GxP (Good Practices) compliance
Regulatory expectations are increasing, and research teams need compliance strategies that are both rigorous and adaptable. For studies involving diagnostics, devices, lab work, or observational data, maintaining quality and integrity without slowing progress is critical.
This whitepaper outlines how Sano uses adaptive planning, transparent communication, and automation to streamline GxP (Good Practices) compliance. We share our approach to applying GCP, GCLP, and good documentation practices. The paper also highlights how we work with certified labs and implement flexible, fit-for-purpose quality systems.
Download the whitepaper to discover how agile, efficient GxP compliance can support high-quality research in a fast-moving regulatory landscape.
